Northeast Financial Consultants Inc - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Northeast Financial Consultants Inc ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$245,000
-20.7%
2,7550.0%0.02%
-5.6%
Q1 2022$309,000
+6.6%
2,755
+46.9%
0.02%0.0%
Q4 2021$290,000
+11.1%
1,8760.0%0.02%
+5.9%
Q3 2021$261,000
+6.1%
1,8760.0%0.02%0.0%
Q2 2021$246,000
+15.0%
1,876
-2.0%
0.02%
-19.0%
Q2 2020$214,000
+7.0%
1,9150.0%0.02%
+16.7%
Q4 2019$200,000
-8.7%
1,9150.0%0.02%
-18.2%
Q2 2019$219,000
-9.1%
1,9150.0%0.02%
-18.5%
Q1 2019$241,0001,9150.03%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders